News
Move over Humira, Skyrizi and Rinvoq are expected to beat the former megablockbuster’s peak sales by the end of this year.
Rumors of Biogen’s disagreements with Eisai have been greatly exaggerated, CEO Chris Viehbacher said during a second quarter ...
11mon MSN
Proto Labs outlines 6% revenue growth target for Q3 2025 while advancing aerospace and defense focus
Q2 2025 Management View Suresh Krishna, President and CEO, opened the call by introducing himself as the new leader and emphasizing his background in supply chain, operations, and general management.
36m
Barchart on MSNTrump Won’t Take Away Tesla’s Subsidies. Does That Make TSLA Stock a Safe Buy Here?
After weeks of escalating tension between two of America’s most high-profile figures — Elon Musk and President Donald Trump — a surprising shift in tone has emerged. In a recent post, Trump denied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results